Form 4: Alignment Healthcare Director Konowiecki Sells Shares to Cover Tax Obligations

Director Joseph S. Konowiecki sold 16,413 shares of Alignment Healthcare to cover tax withholding obligations related to vesting restricted stock units on September 17, 2024.

Summary

• On September 17, 2024, Joseph S. Konowiecki, a director of Alignment Healthcare, Inc. (ALHC), sold 16,413 shares of common stock.
• The sale was executed at a price of $11.77 per share.
• This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Konowiecki directly owns 1,141,808 shares of Alignment Healthcare.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transaction is a routine sale to cover tax obligations and doesn't indicate a change in the director's outlook on the company.

Management Comments

• The transaction does not represent a discretionary trade by the reporting person.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and directors. This type of transaction is generally viewed as a routine financial activity and may not necessarily reflect a change in the insider's confidence in the company's future prospects.

Comparison to Industry Standards

• Comparing this transaction to similar insider sales in the healthcare industry, it's important to consider the size of the sale relative to the individual's total holdings and the company's overall market capitalization.
• For example, if executives at UnitedHealth Group or Humana were to sell shares for tax purposes, the impact on the stock price might be different due to the larger scale of those companies.
• The sale by Konowiecki represents a small fraction of his total holdings, suggesting it's primarily for tax-related purposes rather than a strategic divestment.

Stakeholder Impact

• The sale of shares may have a minimal impact on shareholders, as it is a routine transaction for tax purposes and does not indicate a change in the director's confidence in the company.

Key Dates